Novo Nordisk's analog insulin will be sold cheaply in Walmart

Novo Nordisk will produce an insulin analog for the retail giant Walmart, which will be offering the drug at far lower prices than competing drugs for patients without insurance.

US retail giant Walmart will soon be selling its own brand of analog insulin, which will be produced by Novo Nordisk, according to Bloomberg News.

The insulin analog known as Relion Novolog will be between 58 and 75 percent cheaper than other brands for patients with no insurance, Walmart states in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs